Cancers,
Journal Year:
2023,
Volume and Issue:
15(7), P. 2119 - 2119
Published: April 1, 2023
The
application
of
cannabis
products
in
oncology
receives
interest,
especially
from
patients.
Despite
the
plethora
research
data
available,
added
value
curative
or
palliative
cancer
care
and
possible
risks
involved
are
insufficiently
proven
therefore
a
matter
debate.
We
aim
to
give
recommendation
on
position
clinical
by
assessing
recent
literature.
Various
types
products,
characteristics,
quality
pharmacology
discussed.
Standardisation
is
essential
for
reliable
reproducible
quality.
oromucosal/sublingual
route
administration
preferred
over
inhalation
drinking
tea.
Cannabinoids
may
inhibit
efflux
transporters
drug-metabolising
enzymes,
possibly
inducing
pharmacokinetic
interactions
with
anticancer
drugs
being
substrates
these
proteins.
This
enhance
cytostatic
effect
and/or
drug-related
adverse
effects.
Reversely,
it
enable
dose
reduction.
Similar
likely
used
symptom
management
treating
pain,
nausea,
vomiting
anorexia.
Cannabis
usually
well
tolerated
improve
life
patients
(although
not
unambiguously
proven).
combination
immunotherapy
seems
undesirable
because
immunosuppressive
action
cannabinoids.
Further
warranted
scientifically
support
(refraining
from)
using
cancer.
Cancers,
Journal Year:
2020,
Volume and Issue:
12(7), P. 1985 - 1985
Published: July 21, 2020
In
recent
years,
and
even
more
since
its
legalization
in
several
jurisdictions,
cannabis
the
endocannabinoid
system
have
received
an
increasing
amount
of
interest
related
to
their
potential
exploitation
clinical
settings.
Cannabinoids
been
suggested
shown
be
effective
treatment
various
conditions.
cancer,
is
altered
numerous
types
tumours
can
relate
cancer
prognosis
disease
outcome.
Additionally,
cannabinoids
display
anticancer
effects
models
by
suppressing
proliferation,
migration
and/or
invasion
cells,
as
well
tumour
angiogenesis.
However,
therapeutic
use
currently
limited
symptoms
pain
associated
with
chemotherapy,
while
cytotoxic
drugs
chemotherapy
still
requires
validation
patients.
Along
cannabinoids,
contains
other
compounds
that
also
exert
anti-tumorigenic
actions.
The
anti-cancer
terpenes
flavonoids,
present
cannabis,
are
explored
this
literature
review.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(9), P. 3067 - 3067
Published: April 26, 2020
Cannabis
sativa
is
an
aromatic
annual
flowering
plant
with
several
botanical
varieties,
used
for
different
purposes,
like
the
production
of
fibers,
oil
from
seeds,
and
especially
recreational
or
medical
purposes.
Phytocannabinoids
(terpenophenolic
compounds
derived
plant),
include
well-known
psychoactive
cannabinoid
Δ9-tetrahydrocannabinol,
many
non-psychoactive
cannabinoids,
cannabidiol.
The
endocannabinoid
system
(ECS)
comprises
ligands,
enzymes
synthesis
degradation
such
receptors.
This
widely
distributed
in
gastrointestinal
tract,
where
phytocannabinoids
exert
potent
effects,
particularly
under
pathological
(i.e.,
inflammatory)
conditions.
Herein,
we
will
first
look
at
hemp
as
a
possible
source
new
functional
food
ingredients
nutraceuticals
that
might
be
eventually
useful
to
treat
even
prevent
Subsequently,
briefly
describe
ECS
general
pharmacology
phytocannabinoids.
Finally,
revise
available
data
showing
phytocannabinoids,
cannabidiol,
may
disorders
diseases
tract.
With
increasing
interest
development
foods
healthy
life,
are
hoped
find
place
also
tract
function.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
157, P. 113993 - 113993
Published: Nov. 12, 2022
Abnormal
energy
metabolism,
as
one
of
the
important
hallmarks
cancer,
was
induced
by
multiple
carcinogenic
factors
and
tumor-specific
microenvironments.
It
comprises
aerobic
glycolysis,
de
novo
lipid
biosynthesis,
glutamine-dependent
anaplerosis.
Considering
that
metabolic
reprogramming
provides
various
nutrients
for
tumor
survival
development,
it
has
been
considered
a
potential
target
cancer
therapy.
Cannabinoids
have
shown
to
exhibit
variety
anticancer
activities
unclear
mechanisms.
This
paper
first
reviews
recent
progress
related
signaling
pathways
(reactive
oxygen
species
(ROS),
AMP-activated
protein
kinase
(AMPK),
mitogen-activated
kinases
(MAPK),
phosphoinositide
3-kinase
(PI3K),
hypoxia-inducible
factor-1alpha
(HIF-1α),
p53)
mediating
metabolism
(including
glucose
amino
acid
metabolism).
Then
we
comprehensively
explore
latest
discoveries
possible
mechanisms
effects
cannabinoids
through
regulation
above-mentioned
pathways,
provide
new
targets
insights
prevention
treatment.
Biofilm,
Journal Year:
2024,
Volume and Issue:
7, P. 100175 - 100175
Published: Jan. 1, 2024
Staphylococcus
aureus
can
readily
form
biofilm
which
enhances
the
drug-resistance,
resulting
in
life-threatening
infections
involving
different
organs.
Biofilm
formation
occurs
due
to
a
series
of
developmental
events
including
bacterial
adhesion,
aggregation,
maturation,
and
dispersion,
are
controlled
by
multiple
regulatory
systems.
Rapidly
increasing
research
development
outcomes
on
natural
products
targeting
S.
and/or
regulation
led
an
emergent
application
active
phytochemicals
combinations.
This
review
aimed
at
providing
in-depth
understanding
mechanisms
for
aureus,
outlining
most
important
antibiofilm
strategies
potential
targets
products,
summarizing
latest
progress
combating
with
plant-derived
products.
These
findings
provided
further
evidence
novel
drugs
clinical
therapies.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(18), P. 6740 - 6740
Published: Sept. 14, 2020
Cannabidiol
(CBD)
is
a
non-intoxicating
and
generally
well-tolerated
constituent
of
cannabis
which
exhibits
potential
beneficial
properties
in
wide
range
diseases,
including
cardiovascular
disorders.
Due
to
its
complex
mechanism
action,
CBD
may
affect
the
system
different
ways.
Thus,
we
reviewed
influence
on
this
health
disease
determine
risk
side
effects
during
use
for
medical
wellness
purposes
elucidate
therapeutic
diseases.
Administration
healthy
volunteers
or
animals
usually
does
not
markedly
hemodynamic
parameters.
Although
has
been
found
exhibit
vasodilatory
antioxidant
hypertension,
it
affected
blood
pressure
hypertensive
animals.
Hypotensive
action
mainly
revealed
under
stress
conditions.
Many
positive
have
observed
experimental
models
heart
diseases
(myocardial
infarction,
cardiomyopathy,
myocarditis),
stroke,
neonatal
hypoxic
ischemic
encephalopathy,
sepsis-related
encephalitis,
complications
diabetes,
ischemia/reperfusion
injures
liver
kidneys.
In
these
pathological
conditions
decreased
organ
damage
dysfunction,
oxidative
nitrative
stress,
inflammatory
processes
apoptosis,
among
others.
Nevertheless,
further
clinical
research
needed
recommend
treatment
Molecules,
Journal Year:
2020,
Volume and Issue:
25(3), P. 652 - 652
Published: Feb. 4, 2020
Cannabinoids
are
increasingly-used
substances
in
the
treatment
of
chronic
pain,
some
neuropsychiatric
disorders
and
more
recently,
skin
with
an
inflammatory
component.
However,
various
studies
cite
conflicting
results
concerning
cellular
mechanisms
involved,
while
others
suggest
that
cannabinoids
may
even
exert
pro-inflammatory
behaviors.
This
paper
aims
to
detail
clarify
complex
workings
molecular
setting
main
dermatological
diseases,
their
interactions
other
emerging
applications
these
conditions.
Also,
potential
role
as
antitumoral
drugs
is
explored
relation
component
cancer.
In
vivo
vitro
employed
either
phyto-,
endo-,
or
synthetic
were
considered
this
paper.
regarded
growing
interest
eligible
conditions,
anticancer
effects,
readiness
monitoring
effects
facility
topical
application
contribute
support
use
substances.
Despite
promising
early
results,
further
controlled
human
required
establish
definitive
products
pathophysiology
inflammation
usefulness
clinical
setting.
Biology,
Journal Year:
2022,
Volume and Issue:
11(6), P. 817 - 817
Published: May 26, 2022
Cannabis
sativa
L.
(Cannabis)
and
its
bioactive
compounds,
including
cannabinoids
non-cannabinoids,
have
been
extensively
studied
for
their
biological
effects
in
recent
decades.
Cannabidiol
(CBD),
a
major
non-intoxicating
cannabinoid
Cannabis,
has
emerged
as
promising
intervention
cancer
research.
The
purpose
of
this
review
is
to
provide
insights
into
the
relationship
between
CBD
based
on
research
findings.
anticancer
are
mainly
mediated
via
interaction
with
endocannabinoid
system,
resulting
alleviation
pain
promotion
immune
regulation.
Published
reviews
focused
applications
management
possible
toxicological
excessive
consumption.
In
review,
we
aim
summarize
mechanisms
action
underlying
activities
against
several
common
cancers.
Studies
efficacy
prevention
experimental
models
(i.e.,
cell
culture-
animal-based
assays)
human
clinical
studies
included
review.